搜尋結果

共 200 個結果
頁數:1...2 3 4 5 6 7 8 9 10

荃灣公立何傳耀紀念中學 校長藉數學比賽傳承恩師鼓勵

... 校長和老師,兩位均是Bio PhD,一位中大,一位港大。剛好我們在中大和港大的校友知道有這項比賽,便向他們提議 ...全文

今日信報副刊文化校長訪談王嵐2018年11月26日

Speculators return as China eases market curbs

... hangsheng Bio-technology (002680.CN), the company at the center of a nationwide vaccine safety scandal that faces the risk of delisting. A “special treatment” stock, Changsheng rose the maximum 5 perc ...More

EJ Insight2018-11-16

Scientists launch plan to map genes of all complex life on earth

... the Earth BioGenome Project (EBP) as “the next moonshot for biology” after the Human Genome Project, a 13-year, US$3 billion endeavor to map human DNA which was completed in 2003. The EBP is expected ...More

EJ Insight2018-11-02

Click-on bionic arm could help amputees do the simple things

... Cambridge Bio-Augmentation Systems (CBAS) is working on a "prosthetic interface device" (PID), a neural interface that is integrated into the bone, the skin and the nervous system. Out from the end of ...More

EJ Insight2018-11-01

假人

... 例如將機械人生物化(Bio),Bio+Android便有了Bioroid,Bio+Robot則是Biorobo ...全文

今日信報副刊文化生命通識岑逸飛2018年11月01日

科技園斥60億支援初創

... 物科技──Incu-Bio計劃,對每間公司的研發支援金額提升至最多400萬元。 為鼓勵本地及海外初創、大型企業 ...全文

今日信報財經新聞2018年10月27日

塞拉利昂叫停中資興建機場項目

西非國家塞拉利昂在新政府上台後對「一帶一路」合作項目反悔。 總統馬達.比奧(Madda Bio)近日決定取消投 ...全文

即時新聞中國財經2018年10月12日

塞拉利昂嫌貴 撤「帶路」機場項目

... .比奧(Madda Bio)近日決定取消投資額為4億美元(約31.2億港元)機場項目,認為該機場是由他的前任政 ...全文

今日信報兩岸消息2018年10月12日

Foxconn sees Zhuhai as stepping stone to creating own brand

... tors were biotechnology, up 15.4 percent, petrochemicals with 13.8 percent growth, and electronics and IT, up 11.6 percent. Output of high-tech companies rose 15.9 percent. Actual foreign investment i ...More

EJ Insight2018-09-03

Changsheng made 500,000 substandard baby vaccines: Xinhua

... hangsheng Bio-technology Co. Ltd. of selling 252,600 doses of ineffective DPT vaccines to inoculate children against diphtheria, whooping cough and tetanus, Reuters said. Xinhua said on Wednesday furt ...More

EJ Insight2018-08-16

China vaccine scandal shows, once again, why HK is different

In mid-July, China's state drug administration ordered Changsheng Bio-technology, a company headquartered in Changchun in northeastern China, to stop production of rabies vaccines after it uncovered e ...More

EJ Insight2018-08-16

China vaccine scandal shows, once again, why HK is different

... hangsheng Bio-technology, a company headquartered in Ch ...全文

今日信報時事評論EJ InsightFrank Ching2018年08月16日

Vaccine scandal rocks confidence in China food and drug safety

... hangsheng Bio-technology Ltd. (002680.CN), which was found to have falsified reports about the production and inspection of some 113,000 rabies vaccines, according to the China Food and Drug Administr ...More

EJ Insight2018-07-24

改變製造業的科技

... s)、生物基聚合物(bio-based polymers)以及納米材料,可以製作更穩定、更輕、更耐熱、更耐化學 ...全文

今日信報副刊文化女播天下呂婉瑩2018年06月06日

天婦羅發源地 葡萄牙創新地道菜

... 牙南部的行政總廚Fábio Pombo,於今個春夏為大家帶來8道全新的葡萄牙菜式。新菜式保持着以新派烹調手法來 ...全文

今日信報副刊文化星級餐廳林依純2018年05月17日

涉向美輸鴉片類藥 港註冊公司遭制裁

... 港公司為Zaron Bio-Tech(Asia)Ltd,公司與5名內地人都會被凍結在美國國內的資產,並禁止在美 ...全文

即時新聞時事脈搏2018年04月28日

綠葉製藥迎高增長逢調整買入

... 技術公司Excel Bio Pharm LLC簽署合作及授權協議,合作探索和開發用於下一代腫瘤免疫療法的治療型 ...全文

今日信報理財投資個股策略盧斯2018年04月13日

Why stock listing rules reform is so critical to HK

...  first is bio-tech companies that have not established a track record of revenues and profits, which is currently required by the exchange’s financial eligibility rules. The second is high-growth inno ...More

EJ Insight2018-03-02

HKSTP unveils biotech, AI programs to drive innovation

Hong Kong Science and Technology Parks Corporation (HKSTP) is focusing on biotechnology and artificial intelligence as part of its goal to become a major driver and coordinator of innovation and techn ...More

EJ Insight2018-02-27

Chinese equities: Consumption plays likely to gain traction

... beverage, bio-healthcare, culture and entertainment, and other retail plays all outperformed. Given the emphasis on consumption amid China's economic transformation, as well as the consumption upgrade ...More

EJ Insight2018-02-27

頁數:1...2 3 4 5 6 7 8 9 10

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。